Friday, June 10th, 2016 - Custom Market Insights

The COPD and Asthma hold the largest market share within the global respiratory diseases’ market. As estimated by Global Initiative for Asthma (GINA), approximately 300 million people suffer from Asthma globally. COPD was the 3rd leading cause for death with 3 million people in 2013. Variety of drug-delivery methods such as oral and parenteral delivery have been deployed for treatment of COPD and Asthma; however, the pulmonary drug delivery system is the most effective drug-delivery technology as compared to the other (stated) conventional methods. The pulmonary drug delivery system includes devices such as inhalers and nebulizers – that are types of COPD and Asthma devices. Owing to all of the afore-mentioned factors the global COPD and Asthma devices’ market was valued at $25.3 billion in 2013. The global COPD and Asthma devices market is segmented based on product/device types – inhalers and nebulizers. There are three types of inhalers, namely Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs) and Soft Mist Inhalers (SMIs). Currently, MDIs constitute to the largest market share of about 46% of the global COPD and Asthma devices market.

Do Inquiry For Sample Report @

The DPIs is the fastest growing segment owing to the increase in the adoption rate of DPIs (as compared to other types of inhalers). The ability of DPIs to deliver small and large-sized drug molecules, as well as specialty engineered molecules render it to be the most preferred inhaler by the customers (doctors);therefore, contributing largely to the growth of the DPIs segment market.

The other product type segment, i.e. the Nebulizers, is the device wherein the liquid formulation of drug is dispensed with the help of compressed air. There are various types of nebulizers developed and supplied such as Compressor Nebulizers, Ultrasonic Nebulizers and Mesh Nebulizers. The nebulizers hold a largest market share in the Home Healthcare application, as the product design of nebulizers offers benefits to debilitated patients, geriatrics and children.

Geographically, the COPD and Asthma devices market is segmented into North America, Europe, Asia-Pacific and LAMEA. North America holds the largest market share followed by Europe. Patent expiry of many brands (of inhalers) leads to increased development and supply of such devices by local market players in the Asia-Pacific market; also coupled with the increasing prevalence of the COPD and Asthma diseases in the Asia-Pacific region, the factors will render high market share for the Asia-Pacific region, by 2020. Some of the key market players included in the report are GlaxoSmithKline Plc, Novartis AG, Merck & Co., Inc., AstraZeneca Plc, Philips Healthcare, 3M Health Care, Allied Healthcare Products Inc., Sunovion Pharmaceuticals Inc., GF Healthcare Products, Smith Medicals, Lincare Holdings Inc., and Baxter International.

Contact Profile

Custom Market Insights

Custom Market Insights is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.

Joel John
P: 1-855-465-4651


COPD and Asthma Devices Market, COPD and Asthma Devices Industry, COPD and Asthma Devices Market 2016, Global COPD and Asthma Devices Market




More Formats